Emergencies and Disasters

COVID-19

All COVID-19 flexibilities and waivers, except those stated otherwise on this page, will expire after May 11, 2023. Providers will be required to revert to pre-COVID policies on May 12, 2023. Please the CMS Current Emergencies page for information and updates related to COVID-19.

On this page, view the below information.

Toolkit on COVID-19 Vaccine: Health Insurance Issuers and Medicare Advantage Plans

CMS is issuing a toolkit to help health insurance issuers, and Medicare Advantage plans identify the issues that need to be considered and addressed in order to provide coverage and reimbursement for the COVID-19 vaccine and administration.

COVID-19 Vaccine, Monoclonal Antibodies and Administration

For detailed information on COVID-19 vaccine, monoclonal antibodies, and administration, including CPT and HCPCS coding, pricing, and effective dates, please visit the CMS Vaccine Pricing webpage.

Incident-To

During the COVID-19 PHE CMS temporarily changed the definition of "direct supervision" to allow the supervising health care professional to be immediately available through virtual presence using real-time audio/video technology instead of requiring their physical presence. This flexibility will be extended through December 31, 2023.

Telehealth

Through the Consolidated Appropriations Act (CAA) 2023, CMS has extended the following Telehealth waivers and flexibilities until the end of 2023.

  • Services temporarily added to Medicare Telehealth will be available through 2023.
  • Providers may continue to use the POS they would have used if rendering the service in person with modifier-95 appended until end of 2023.

CMs has also extended the following flexibilities until the end of 2024:

  • Telehealth services may be furnished in any geographic area and originating site (including the patient’s home) until the end of 2024.
  • Telehealth services may be furnished by physical therapists, occupational therapists, speech-language pathologists, and audiologists until the end of 2024.
  • Delay of the face-to-face requirements for telehealth services through the end of 2024.

COVID-19: Advance Payment

CMS Announces New Repayment Terms for Medicare Loans made to Providers during COVID-19

CMS announced amended terms for payments issued under the Accelerated and Advance Payment Program. Providers were required to make payments starting August of 2020, but with this action, repayment will be delayed until one year after payment was issued.

See CMS Announces New Repayment Terms for Medicare Loans made to Providers during COVID-19 for complete information.

View the CMS COVID-19 Accelerated and Advance Payment (CAAP) Repayment & Recovery Frequently Asked Questions resource for additional information.

Enrollment Guidelines

COVID-19 Hotline Enrollments and Temporary Enrollment

Providers who temporarily enrolled as Medicare a provider for the duration of the COVID PHE will receive notification letters from their MAC granting them the option to become fully enrolled. Providers who do not respond within 90 days of their letter will have their enrollment terminated.

Telehealth

Providers are not required to report their home address if providing telehealth services from their home until the end of 2024.

  • If a provider submits a paper/web application and the MAC is able to clearly determine that the application is to add a home address, MAC shall return the application.
  • MACs shall note the following as the return reason in the letter "This application is not needed for the transaction in question. Providers are not required to report their home address if providing telehealth services from their home."

Revalidation

  • For applications received prior to March 1, 2020, Noridian will not deactivate for non-response to development or revalidation.
  • Revalidation due date lists will resume afterwards, consistent with pre-PHE revalidation workloads.

Enrollment of Ambulatory Surgical Centers (ASCs) as Hospitals

When an ASC enrolled as a hospital, their billing privileges as ASCs were terminated once the approval for the hospital enrollment had been established. An ASCs hospital enrollment will terminate upon termination of the COVID PHE. ASCs must submit a notification of intent to convert back to an ASC to the applicable CMS Survey and Operations Group (SOG) location on or before the conclusion of the PHE via email or mailed letter.

If the ASC wishes to participate as a hospital after the PHE has ended, it must submit form CMS-855A to begin the process of enrollment and initial certification as a hospital under the regular processes. An initial survey, either done by the State Agency or Accreditation Organization, will be conducted to determine compliance with all applicable hospital Conditions of Participation.

Resources

In the event of a national or regional catastrophe or disaster, the Emergency Response and Recovery webpage contains information about the most recent emergencies and disasters.

Access the below topic related information from this page.

Access additional resources that may assist providers when handling claims related inquiries from the below.

 

Last Updated Dec 10 , 2023

Related Articles

paginationType noridian
Articles Source Posted
Laboratories and Other Providers Must Follow Mandatory Assignment Regulations for COVID-19 Tests and Test Kits 07/18/2023
Claims Must be Filed for Covered COVID-19 Tests 07/18/2023
COVID-19 Over the Counter (OTC) Test Coverage Ends May 11, 2023 04/05/2023
MLN Connects Newsletter: COVID-19 Public Health Emergency (PHE) New Overview Fact Sheet - Feb 27, 2023 02/27/2023
Public Health Emergency (PHE) 1135 Waivers: Updated Guidance for Providers 02/24/2023
New & Expanded Flexibilities for RHCs & FQHCs during the COVID-19 PHE - Revised SE20016 11/30/2022
MLN Connects Special Edition - August 18, 2022 - Creating a Roadmap for the End of the COVID-19 Public Health Emergency 08/18/2022
COVID-19 Monoclonal Antibody Therapy Q0222 Injection, Bebtelovimab, 175 mg Payment Allowance Update 08/11/2022
COVID-19 Novavax Vaccine, Adjuvanted New Codes 07/21/2022
COVID-19: New Administration Code 0074A for Pfizer Pediatric Vaccine Booster Dose 05/26/2022
Update to Publication 100-04, Chapter 18 and Publication 100-02, Chapter 15, Section to Add Data Regarding COVID-19 and its Administration to Current Claims Processing Requirements and Other General Updates CR12634 04/20/2022
COVID-19: New Codes for Moderna Vaccine Booster Doses 04/14/2022
MLN Connects Special Edition - April 7, 2022 - Returning to Certain Pre-COVID-19 Policies & Coverage of Monoclonal Antibodies for Alzheimer's Disease Stakeholder Call 04/08/2022
MLN Connects Special Edition - April 6, 2022 - Eligible Individuals Can Receive Second COVID-19 Booster Shot at No Cost 04/06/2022
COVID-19 Monoclonal Antibodies: Revised Emergency Use Authorization for EVUSHELD Q0221 03/17/2022
New & Expanded Flexibilities for RHCs & FQHCs during the COVID-19 PHE - Revised SE20016 01/19/2022
MLN Connects Special Edition - December 2, 2021 - CMS Encourages People with Medicare to get COVID-19 Vaccine Booster Shot 12/02/2021
MLN Connects Special Edition - December 28, 2020 - Medicare FFS Claims: 2% Payment Adjustment (Sequestration) Suspended Through March 12/28/2020
MLN Connects Special Edition - December 22, 2020 - COVID-19 Vaccine Codes: Updated Effective Date for Moderna 12/22/2020